The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 15, 2010

Filed:

Jan. 20, 2006
Applicants:

Eva Againe Csongor, Budapest, HU;

Janos Galambos, Budapest, HU;

Katalin Nogradi, Budapest, HU;

Istvan Vago, Budapest, HU;

Istvan Gyertyan, Budapest, HU;

Bela Kiss, Budapest, HU;

Istvan Laszlovszky, Budapest, HU;

Judit Laszy, Nagykovacsi, HU;

Katalin Saghy, Budapest, HU;

Inventors:

Eva Againe Csongor, Budapest, HU;

Janos Galambos, Budapest, HU;

Katalin Nogradi, Budapest, HU;

Istvan Vago, Budapest, HU;

Istvan Gyertyan, Budapest, HU;

Bela Kiss, Budapest, HU;

Istvan Laszlovszky, Budapest, HU;

Judit Laszy, Nagykovacsi, HU;

Katalin Saghy, Budapest, HU;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 25/00 (2006.01); A61K 31/535 (2006.01); A61K 31/497 (2006.01); A61K 31/4965 (2006.01); C07D 241/00 (2006.01); C07D 295/00 (2006.01); C07D 401/00 (2006.01); C07D 403/00 (2006.01); C07D 413/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to new D3 and D2 dopamine receptor subtype preferring ligands of formula (I): wherein Rand Rrepresent independently a substituent selected from hydrogen, alkyl, aryl, cycloalkyl, aroyl, or Rand Rmay form a heterocyclic ring with the adjacent nitrogen atom; X represents an oxygen or sulphur atom; n is an integer of from 1 to 2, and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates thereof, to the processes for producing the same, to pharmaceutical compositions containing the same and to their use in therapy and/or prevention of a condition which requires modulation of dopamine receptors.


Find Patent Forward Citations

Loading…